Comparison of the EGFR resistance mutation profiles generated by EGFR-targeted tyrosine kinase inhibitors and the impact of drug combinations

Egle Avizienyte(AstraZeneca (United Kingdom)), Andrew P. Garner(AstraZeneca (United Kingdom))
Biochemical Journal
July 2, 2008
Cited by 89


Related Papers

No related papers found

Powered by citation graph analysis